GBA1 and Parkinson disease: Decreased GBA1 activity results in mitochondrial dysfunction with loss of mitochondrial membrane potential, reduced ATP, increased oxidative stress and fragmented mitochondria and is observed in GD fibroblasts, GD cell and animal models and is a well-established feature of Parkinson’s disease (PD)15–17.